immunotherapy
209 projects
HEIndividual fellowship2023–2025Portugal
TRAIN · Tumor Regulation Assisted by Immunity and Nanotechnology
HEIndividual fellowship2023–2026Netherlands
PCPanCel · Modulating the physicochemical properties of polymer-based nanovaccines to communicate with immune cells
HEIndividual fellowship2023–2025Spain
PRE-BIT · Understanding the role of B cell phenotypes as a predictor of the efficacy and prognosis of allergen immunotherapy using allergic rhinitis to house dust mite as a model
HEIndividual fellowship2023–2025Belgium
DPP9-TACDrug · DPP9 degradation-induced pyroptosis for treatment of acute myeloid leukemia
HEDoctoral network2023–2027France
Melomanes · Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles
25 partners · 11 countries
HEIndividual fellowship2023–2024France
MOTM · Metabolic optimisation of intra-tumoral T cell motility
HEIndividual fellowship2023–2025Germany
CASSIS · A single-cell atlas of human soft tissue sarcoma ecosystems with focus on mechanisms of immune evasion
HEIndividual fellowship2022–2024Germany
EXPL ANTIVIR ENDONUC · Role and modulation of Zinc-finger antiviral protein and antiviral Regnase-1-like endonucleases
HEIndividual fellowship2022–2024Portugal
EVOLVE · Isolation and Analysis of Extracellular Vesicles using OptofLuidics for the eValuation of Microsatellite Instability in Endometrial Cancer
2 partners · 2 countries
HEIndividual fellowship2022–2024Germany
engineereD to Clear · Investigation on the vaccination potential of IL4i1 deficient dendritic cells in Chronic lymphocytic leukemia
HEIndividual fellowship2022–2024Sweden
RePLASTIC · Uncovering the Regulators of Cellular Plasticity by Direct Reprogramming
H2020Individual fellowship2022–2024Netherlands
BreaKer · Dissecting how breast cancer-associated inflammation shapes invariant natural killer T cell activity during metastatic progression
H2020Individual fellowship2022–2024United Kingdom
Chemical Mutagenesis · a powerful tool for the creation of a library of nanobodies
H2020Individual fellowship2022–2023Spain
GIPTRAP · Therapeutic potential of recombinant antibodies to neutralize immunogenic peptides in celiac disease
H2020Individual fellowship2022–2025Switzerland
MIRIC · Myeloid Cells: Investigating their Role for Immunotherapy in Cancer
H2020Individual fellowship2021–2024Luxembourg
EVIL · Reprogramming of the leukemic microenvironment by small extracellular vesicles: from characterization to therapeutic application
H2020Individual fellowship2021–2023Switzerland
MT-PoINT · Motif in T cells for the Prediction of INTeractions
H2020Individual fellowship2021–2023Belgium
ECONOMY · Endothelial Cells - an Overlooked Non-hematopoietic cOmponent of tuMor immunitY
H2020Individual fellowship2021–2023Switzerland
NERVASION · Targeting microenvironment of cancer-invaded-nerves in pancreatic adenocarcinoma.
H2020Individual fellowship2021–2025Germany
milieuPCa · Defining the immunosuppressive milieu of prostate cancer with single cell Omics technologies
H2020Individual fellowship2021–2023Switzerland
CINPinCB · Deciphering tumor-promoting mechanisms mediated by neutrophils in vivo
H2020Individual fellowship2021–2024Spain
CD28 · Probing CD28 as checkpoint for T cell co-stimulation in cancer and infection
2 partners · 2 countries
H2020Doctoral network2021–2025France
CAPSTONE · Training experts in antigen processing to deliver new drug prototypes for cancer and autoimmune diseases
10 partners · 7 countries
H2020Doctoral network2021–2025Germany
T-OP · Training Network for Optimizing Adoptive T cell Therapy of Cancer
12 partners · 7 countries